Interactions
Organism
Gene Name
| S.No | BIMP ID | Organism | Action | References |
|---|---|---|---|---|
| 1 | BIMP105492 | Homo sapiens (human) | [parathion co-treated with atropine] results in increased expression of ABL1 mrna|parathion results in increased expression of ABL1 mRNA | |
| 2 | BIMP102866 | Homo sapiens (human) | [polyethyleneimine binds to gold] which results in decreased expression of ABL1 mRNA | |
| 3 | BIMP091591 | Homo sapiens (human) | Ficusin binds to ABL1 protein | |
| 4 | BIMP091243 | Homo sapiens (human) | Phenylephrine results in increased phosphorylation of ABL1 protein|abl1 protein affects the reaction [phenylephrine promotes the reaction [CRK protein binds to WASL protein]]|abl1 protein affects the susceptibility to phenylephrine|abl1 protein affects the reaction [phenylephrine promotes the reaction [BCAR1 protein binds to CRK protein]]|abl1 protein affects the reaction [phenylephrine results in increased phosphorylation of BCAR1 protein] | |
| 5 | BIMP091110 | Homo sapiens (human) | Testosterone results in increased expression of ABL1 mrna|[testosterone co-treated with calcitriol] results in increased expression of ABL1 mRNA | |
| 6 | BIMP094277 | Homo sapiens (human) | Bisphenol A results in decreased expression of ABL1 mRNA | |
| 7 | BIMP094277 | Homo sapiens (human) | Bisphenol A results in decreased methylation of ABL1 gene|[bisphenol A co-treated with fulvestrant] affects the methylation of ABL1 gene | |
| 8 | BIMP094277 | Homo sapiens (human) | Bisphenol A results in increased expression of ABL1 mRNA | |
| 9 | BIMP094277 | Homo sapiens (human) | Bisphenol A results in increased expression of ABL1 protein | |
| 10 | BIMP094277 | Homo sapiens (human) | Bisphenol A affects the expression of ABL1 mRNA | |
| 11 | BIMP100516 | Homo sapiens (human) | Nilotinib inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased chemical synthesis of histamine]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased chemical synthesis of histamine]|[bcr protein mutant form binds to ABL1 protein mutant form] which results in increased chemical synthesis of histamine|imatinib mesylate inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased chemical synthesis of histamine] | |
| 12 | BIMP094130 | Homo sapiens (human) | Triptonide affects the expression of ABL1 mRNA | |
| 13 | BIMP034250 | Homo sapiens (human) | Capsaicin results in increased expression of ABL1 mRNA | |
| 14 | BIMP026486 | Homo sapiens (human) | [methylnitronitrosoguanidine co-treated with cadmium chloride] results in increased expression of ABL1 mrna|[methylnitronitrosoguanidine co-treated with okadaic acid] results in increased expression of ABL1 mrna|[methylnitronitrosoguanidine co-treated with tetradecanoylphorbol acetate] results in increased expression of ABL1 mRNA | |
| 15 | BIMP066605 | Homo sapiens (human) | Sorafenib results in decreased activity of ABL1 protein mutant form|sorafenib inhibits the reaction [[ABL1 protein mutant form co-treated with adenosine triphosphate] results in increased phosphorylation of CRKL protein]|sorafenib results in decreased phosphorylation of ABL1 protein mutant form | |
| 16 | BIMP066605 | Homo sapiens (human) | - |
No ref
|
| 17 | BIMP040289 | Homo sapiens (human) | [platycodin D co-treated with imatinib mesylate] results in decreased expression of ABL1 protein | |
| 18 | BIMP037097 | Homo sapiens (human) | Abrine results in increased expression of ABL1 mRNA | |
| 19 | BIMP063649 | Homo sapiens (human) | ABL1 protein promotes the reaction [acetaldehyde results in increased phosphorylation of and results in decreased activity of PPARG protein]|imatinib mesylate inhibits the reaction [acetaldehyde results in increased activity of ABL1 protein]|acetaldehyde results in increased activity of ABL1 protein | |
| 20 | BIMP063649 | Homo sapiens (human) | Aldehydes results in decreased expression of ABL1 mRNA | |
| 21 | BIMP019430 | Homo sapiens (human) | Acetylcysteine inhibits the reaction [NSC 680410 results in decreased phosphorylation of ABL1 protein] | |
| 22 | BIMP073537 | Homo sapiens (human) | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased chemical synthesis of histamine]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased expression of HDC mrna] | |
| 23 | BIMP073133 | Homo sapiens (human) | Gallic acid promotes the reaction [imatinib mesylate results in decreased phosphorylation of [BCR protein mutant form binds to ABL1 protein mutant form]]|gallic acid results in decreased phosphorylation of [BCR protein mutant form binds to ABL1 protein mutant form]|imatinib mesylate promotes the reaction [gallic acid results in decreased phosphorylation of [BCR protein mutant form binds to ABL1 protein mutant form]] | |
| 24 | BIMP073073 | Homo sapiens (human) | - |
No ref
|
| 25 | BIMP072841 | Homo sapiens (human) | Glyphosate results in increased expression of ABL1 mRNA | |
| 26 | BIMP077135 | Homo sapiens (human) | Resveratrol results in decreased expression of [BCR protein mutant form binds to ABL1 protein mutant form]|purmorphamine inhibits the reaction [resveratrol results in decreased expression of [BCR protein mutant form binds to ABL1 protein mutant form]] | |
| 27 | BIMP074364 | Homo sapiens (human) | Beta-glucans results in decreased expression of ABL1 mRNA | |
| 28 | BIMP074172 | Homo sapiens (human) | Myristicin results in decreased expression of ABL1 mRNA | |
| 29 | BIMP072381 | Homo sapiens (human) | Coumarin results in decreased phosphorylation of ABL1 protein | |
| 30 | BIMP072300 | Homo sapiens (human) | [[[doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein] which results in decreased expression of BCL2 protein|[[[doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein] which results in increased expression of PMAIP1 protein|[[[doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein] which results in increased expression of FAS protein|[doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein|[[doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein|[[[doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein] which results in increased expression of BAX protein|[[[doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein] which results in increased expression of TNFRSF10B protein | |
| 31 | BIMP072300 | Homo sapiens (human) | [TP53 protein affects the susceptibility to doxorubicin] which affects the expression of ABL1 mRNA | |
| 32 | BIMP072198 | Homo sapiens (human) | Valproic acid affects the expression of ABL1 mRNA | |
| 33 | BIMP072198 | Homo sapiens (human) | Valproic acid results in increased expression of ABL1 mRNA | |
| 34 | BIMP071352 | Homo sapiens (human) | - |
No ref
|
| 35 | BIMP070955 | Homo sapiens (human) | Butyraldehyde results in decreased expression of ABL1 mRNA | |
| 36 | BIMP071712 | Homo sapiens (human) | ABL1 results in decreased susceptibility to daunorubicin | |
| 37 | BIMP071142 | Homo sapiens (human) | Chloroquine promotes the reaction [ABL1 protein mutant form binds to YWHAQ protein]|chloroquine promotes the reaction [ABL1 protein mutant form binds to BECN1 protein] | |
| 38 | BIMP070286 | Homo sapiens (human) | Caffeine affects the phosphorylation of ABL1 protein | |
| 39 | BIMP068482 | Homo sapiens (human) | Benzo(a)pyrene affects the methylation of ABL1 5' UTR | |
| 40 | BIMP082936 | Homo sapiens (human) | [alvocidib co-treated with bortezomib co-treated with ABL1 protein] results in decreased phosphorylation of LYN protein|[alvocidib co-treated with bortezomib] results in decreased expression of ABL1 protein|[alvocidib co-treated with bortezomib co-treated with ABL1] results in decreased phosphorylation of CRKL protein | |
| 41 | BIMP082885 | Homo sapiens (human) | T-2 toxin results in decreased expression of ABL1 mRNA | |
| 42 | BIMP082635 | Homo sapiens (human) | Rottlerin inhibits the reaction [[ABL1 protein results in increased phosphorylation of and results in decreased activity of PPARG protein] which results in increased expression of COL1A1 protein] | |
| 43 | BIMP087829 | Homo sapiens (human) | - |
No ref
|
| 44 | BIMP088283 | Homo sapiens (human) | Cytochalasin D results in increased phosphorylation of ABL1 protein|egf protein inhibits the reaction [cytochalasin D results in increased phosphorylation of ABL1 protein] | |
| 45 | BIMP078290 | Homo sapiens (human) | Myrtucommulone A results in decreased expression of ABL1 mRNA | |
| 46 | BIMP078487 | Homo sapiens (human) | Cocaine affects the expression of ABL1 mRNA | |
| 47 | BIMP090535 | Homo sapiens (human) | [estradiol co-treated with TGFB1 protein] results in increased expression of ABL1 mRNA | |
| 48 | BIMP090535 | Homo sapiens (human) | ABL1 protein results in increased susceptibility to estrogens | |
| 49 | BIMP082126 | Homo sapiens (human) | Calcitriol results in increased expression of ABL1 mrna|[testosterone co-treated with calcitriol] results in increased expression of ABL1 mRNA | |
| 50 | BIMP082231 | Homo sapiens (human) | Genistein results in increased expression of ABL1 mRNA | |
| 51 | BIMP082231 | Homo sapiens (human) | - |
No ref
|
| 52 | BIMP082498 | Homo sapiens (human) | Mangiferin results in decreased expression of ABL1 mRNA | |
| 53 | BIMP082095 | Homo sapiens (human) | Quercetin results in decreased expression of ABL1 protein | |
| 54 | BIMP082095 | Homo sapiens (human) | - |
No ref
|
| 55 | BIMP091061 | Homo sapiens (human) | Ethinyl estradiol affects the expression of ABL1 mRNA | |
| 56 | BIMP091061 | Homo sapiens (human) | Ethinyl estradiol results in increased expression of ABL1 mrna|[tetrachlorodibenzodioxin co-treated with ethinyl estradiol] results in increased expression of ABL1 mRNA | |
| 57 | BIMP090994 | Homo sapiens (human) | Sorafenib inhibits the reaction [[ABL1 protein mutant form co-treated with adenosine triphosphate] results in increased phosphorylation of CRKL protein]|[abl1 protein mutant form co-treated with adenosine triphosphate] results in increased phosphorylation of CRKL protein | |
| 58 | BIMP090994 | Homo sapiens (human) | ABL1 protein mutant form results in increased chemical synthesis of adenosine triphosphate |